PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.81%
Net income growth under 50% of MCHP's 220.44%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-15.81%
Negative yoy D&A while MCHP is 0.31%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-133.33%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-129.19%
Both reduce yoy usage, with MCHP at -631.58%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
22.58%
AR growth while MCHP is negative at -1149.49%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-261.54%
Negative yoy inventory while MCHP is 123.08%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-254.29%
Both negative yoy AP, with MCHP at -73.30%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-49.25%
Negative yoy usage while MCHP is 210.08%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
40.00%
Some yoy increase while MCHP is negative at -39.70%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-2.92%
Both yoy CFO lines are negative, with MCHP at -11.87%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-163.79%
Both yoy lines negative, with MCHP at -158.88%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-86.01%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-118.37%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
105.93%
Liquidation growth of 105.93% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
94.86%
We have some outflow growth while MCHP is negative at -22.72%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-152.15%
Both yoy lines negative, with MCHP at -22.72%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
63.21%
Debt repayment 1.25-1.5x MCHP's 50.83%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-30.67%
Negative yoy issuance while MCHP is 89.62%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-2.16%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.